# A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication

> **NCT02446561** · PHASE1 · COMPLETED · sponsor: **Mundipharma Research Limited** · enrollment: 32 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** MRXXX
- **DRUG:** MR1XXX
- **DRUG:** MR2XXX
- **DRUG:** MR3XXX

## Key facts

- **NCT ID:** NCT02446561
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02446561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02446561, "A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02446561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*